SIHUAN PHARM: Notification Letter and Request Form to Non-registered Holder
Apr 26 04:47 ET
SIHUAN PHARM: Notification Letter and Change Request Form to Registered Shareholder
Apr 26 04:44 ET
SIHUAN PHARM: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Apr 26 04:42 ET
SIHUAN PHARM: NOTICE OF ANNUAL GENERAL MEETING
Apr 26 04:40 ET
SIHUAN PHARM: PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Apr 26 04:38 ET
SIHUAN PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023
Apr 26 04:36 ET
SIHUAN PHARM: ANNUAL REPORT 2023
Apr 26 04:33 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-THREE PRODUCTS OF THE INSULIN ASPART SERIES DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED BID-WINNING QUALIFICATION IN THE SPECIALISING RENEWAL IN INSULIN PROCUREMENT
Apr 25 05:17 ET
SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 2 04:04 ET
SIHUAN PHARM: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Mar 28 00:17 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED CLASS III MEDICAL DEVICE REGISTRATION CERTIFICATE FROM NMPA FOR EXCLUSIVELY DISTRIBUTED DUAL WAVE RF TREATMENT DEVICE SYLFIRM X
Mar 25 00:00 ET
SIHUAN PHARM: NOTICE OF BOARD MEETING
Mar 18 04:31 ET
SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 1 03:02 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - PARTICIPATION IN THE CONSORTIUM WHO WAS SELECTED AS THE PRE-RESTRUCTURING INVESTOR FOR THE BANKRUPTCY AND RESTRUCTURING PROJECT OF JI YAO HOLDING
Feb 7 06:49 ET
SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 1 03:03 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-HUISHENG BIOPHARMACEUTICAL''S SGLT-2 INHIBITOR INNOVATIVE DRUG PROLINE JANAGLIFLOZIN TABLETS OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA
Jan 22 17:06 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - FOUR NON-PVC SOLID-LIQUID DOUBLE CHAMBER BAG PRODUCTS, DEVELOPED BY SIHUAN PHARMACEUTICAL''S ASSOCIATE COMPANY BEIJING RUIYE, ARE NEWLY INCLUDED IN NRDL 2023
Jan 9 07:54 ET
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT-THREE INSULIN ASPART PRODUCTS DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA
Jan 7 23:00 ET
SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 3 03:00 ET
SIHUAN PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 1, 2023 03:02 ET
No Data
No Data